| Autor: |
Dassouli, Ryme, Douhi, Zakia, Kacimi, Imane, Tahri, Kenza, Baybay, Hanane, Elloudi, Sara, Mernissi, Fatima Zahra |
| Předmět: |
|
| Zdroj: |
Our Dermatology Online / Nasza Dermatologia Online; Oct2023, Vol. 14 Issue 4, p457-458, 2p |
| Abstrakt: |
This article discusses a case of erythema pigmentosa fixata (EPF) caused by the drug nifuroxazide. EPF is a delayed-type toxidermia characterized by a recurrent rash and residual hyperpigmentation. The patient in this case study experienced a rash after taking nifuroxazide for a digestive issue, which evolved into post-inflammatory hyperpigmentation. A biopsy confirmed the diagnosis of EPF, and the patient had no recurrences after discontinuing the drug. Nifuroxazide is commonly prescribed for digestive diseases and has been associated with various adverse effects, including skin reactions. EPF is most often benign but can occasionally be bullous and affect mucosal areas. It is recommended to perform patch tests to identify the responsible drug. This is the first reported case of EPF induced by nifuroxazide. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
